XERIS PHARMACEUTICALS INC
DelistedCIK 1346302fmd_0VKNTPPW6DKYGX4HTP6X4658NDManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2017 to Jun 30, 2021, 17 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|
| Total revenues | 0 | 0 | 2 | 20 |
| Cost of revenue | 0 | 0 | 2 | 9 |
| Gross profit | 2 | 2 | 1 | 11 |
| Research and development | 20 | 41 | 60 | 21 |
| Selling, general and administrative | 8 | 21 | 63 | 74 |
| Total operating expenses | 28 | 62 | 123 | 95 |
| Operating income | (27) | (59) | (122) | (84) |
| Interest expense | (0) | 3 | (7) | (11) |
| Other non-operating income (expense) | 0 | (1) | (4) | (8) |
| Income tax expense | 0 | 0 | (0) | (0) |
| Net income | (27) | (60) | (126) | (91) |